33
Participants
Start Date
October 31, 2008
Primary Completion Date
February 28, 2015
Study Completion Date
February 28, 2015
Sirolimus
Taken orally at different dose levels depending upon enrollment time period
Vandetanib
Taken orally at different dose levels depending upon enrollment time period
Massachusetts General Hospital, Boston
Dana-Farber Cancer Instiute, Boston
Collaborators (1)
Brigham and Women's Hospital
OTHER
Dana-Farber Cancer Institute
OTHER
AstraZeneca
INDUSTRY
Massachusetts General Hospital
OTHER